Skip to main content
Signal8

Granfield Christine

SEC insider (Form 3/4/5 filer). CIK 0001822190. VP, Head of Reg Affairs/Qual at LEAP THERAPEUTICS, INC. (LPTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 28, 2025. Located in CAMBRIDGE, MA.

Companies Granfield Christine has filed insider reports for

  • LEAP THERAPEUTICS, INC. (LPTX): Officer, VP, Head of Reg Affairs/Qual
Granfield Christine profile photo

Granfield Christine

CIK: 0001822190

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LEAP THERAPEUTICS, INC. logo
LPTX

LEAP THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • LEAP THERAPEUTICS, INC. logo
    LPTX

    LEAP THERAPEUTICS, INC.

    Mar 28, 2025
    Exercise
    Direct
    22.5K shares-
  • LEAP THERAPEUTICS, INC. logo
    LPTX

    LEAP THERAPEUTICS, INC.

    Mar 28, 2025
    Tax Payment
    Direct
    6.6K shares at avg. $0.32$2K
  • LEAP THERAPEUTICS, INC. logo
    LPTX

    LEAP THERAPEUTICS, INC.

    Oct 2, 2024
    Award

    Employee Stock Option (Right to Buy)

    Direct
    85K shares-

1-3 of 3